Physician profile
Chloe Cherelle Singleton
NPI 1114635620
$888.98
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $424 · 2024: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $824 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $824.03 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $237.50 | 2023-2024 | Veozah |
| Viiv Healthcare Company | $116.15 | 2024 | Dovato, Apretude |
| Gilead Sciences, INC. | $112.13 | 2024 | Descovy |
| Merck Sharp & Dohme LLC | $85.27 | 2024 | Delstrigo, Pifeltro |
| Exeltis, USA INC. | $53.36 | 2023-2024 | Slynd |
| Hologic Sales and Service, LLC | $46.17 | 2023 | Omni Hysteroscope, Novasure |
| Pfizer INC. | $44.10 | 2023-2024 | |
| Mayne Pharma Commercial LLC | $36.54 | 2023 | |
| Novo Nordisk INC | $32.35 | 2023 | Wegovy |
| Ethicon US, LLC | $27.18 | 2023 | Ethicon, Vistaseal, Dermabond Prineo |
| Theratechnologies INC. | $27.10 | 2024 | Egrifta, Trogarzo |
| Millicent US INC | $19.75 | 2024 | Femring, Intrarosa |
| Mycovia Pharmaceuticals, INC. | $18.90 | 2023 | Vivjoa |
| Bayer Healthcare Pharmaceuticals INC. | $18.61 | 2024 | |
| Exact Sciences Corporation | $13.87 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chloe Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.